BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36519289)

  • 21. Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
    Abdul-Hussein M; Freeman J; Castell D
    Pharmacotherapy; 2015 Dec; 35(12):1124-9. PubMed ID: 26621819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are Proton Pump Inhibitors More Effective Than Histamine-2-Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients? A Systematic Review and Meta-Analysis of Cohort Studies.
    He N; Yan Y; Su S; Ge Q; Zhai S
    Ann Pharmacother; 2022 Sep; 56(9):988-997. PubMed ID: 34971320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of post-stroke pneumonia with proton pump inhibitors, H2 receptor antagonists and mucoprotective agents: A retrospective nationwide cohort study.
    Song TJ; Kim J
    PLoS One; 2019; 14(5):e0216750. PubMed ID: 31067267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of Acid Suppressive Therapy With Cardiac Mortality in Heart Failure Patients.
    Yoshihisa A; Takiguchi M; Kanno Y; Sato A; Yokokawa T; Miura S; Abe S; Misaka T; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Takeishi Y
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28512114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased risk of exacerbating gastrointestinal disease among elderly patients following treatment with calcium channel blockers.
    Hamada A; Ishii J; Doi K; Hamada N; Miyazaki C; Hamada T; Ohwaki Y; Wada M; Nakashima K
    J Clin Pharm Ther; 2008 Dec; 33(6):619-24. PubMed ID: 19138239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
    Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
    Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranitidine Use and Gastric Cancer Among Persons with Helicobacter pylori.
    Kumar S; Goldberg DS; Kaplan DE
    Dig Dis Sci; 2022 May; 67(5):1822-1830. PubMed ID: 33856609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histamine H2 receptor antagonist exposure was related to decreased all-cause mortality in critical ill patients with heart failure: a cohort study.
    Huang YH; Cai WK; Yin SJ; Wang P; Li ZR; Yang Q; Zhou T; Meng R; Yang M; Guo Y; He GH
    Eur J Prev Cardiol; 2022 Oct; 29(14):1854-1865. PubMed ID: 35707983
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse reactions to H2-receptor antagonists in Denmark before and after transfer of cimetidine and ranitidine to over-the-counter status.
    Andersen M; Schou JS
    Pharmacol Toxicol; 1991 Oct; 69(4):253-8. PubMed ID: 1683484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
    Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
    Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Use of Gastric Antisecretory Drugs in Hospitalized Pediatric Patients.
    Locci C; Cuzzolin L; Cheri G; Saderi L; Sotgiu G; Antonucci R
    J Clin Med; 2023 Jan; 12(1):. PubMed ID: 36615168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.
    Scally B; Emberson JR; Spata E; Reith C; Davies K; Halls H; Holland L; Wilson K; Bhala N; Hawkey C; Hochberg M; Hunt R; Laine L; Lanas A; Patrono C; Baigent C
    Lancet Gastroenterol Hepatol; 2018 Apr; 3(4):231-241. PubMed ID: 29475806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multicenter, randomized, prospective study of 14-day ranitidine bismuth citrate- vs. lansoprazole-based triple therapy for the eradication of Helicobacter pylori in dyspeptic patients.
    Avşar E; Tiftikçi A; Poturoğlu S; Erzin Y; Kocakaya O; Dinçer D; Yıldırım B; Güliter S; Türkay C; Yılmaz U; Onuk MD; Bölükbaş C; Ellidokuz E; Bektaş A; Taşan G; Aytuğ N; Ateş Y; Kaymakoğlu S
    Turk J Gastroenterol; 2013; 24(4):316-21. PubMed ID: 24254262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of gastrointestinal bleeding prophylaxis in critically ill patients: an updated systematic review and network meta-analysis of randomized trials.
    Wang Y; Ge L; Ye Z; Siemieniuk RA; Reintam Blaser A; Wang X; Perner A; Møller MH; Alhazzani W; Cook D; Guyatt GH
    Intensive Care Med; 2020 Nov; 46(11):1987-2000. PubMed ID: 32833040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis.
    Gough AL; Long RG; Cooper BT; Fosters CS; Garrett AD; Langworthy CH
    Aliment Pharmacol Ther; 1996 Aug; 10(4):529-39. PubMed ID: 8853756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
    Brown TJ; Hooper L; Elliott RA; Payne K; Webb R; Roberts C; Rostom A; Symmons D
    Health Technol Assess; 2006 Oct; 10(38):iii-iv, xi-xiii, 1-183. PubMed ID: 17018227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk of lower gastrointestinal bleeding in low-dose aspirin users.
    Chen WC; Lin KH; Huang YT; Tsai TJ; Sun WC; Chuah SK; Wu DC; Hsu PI
    Aliment Pharmacol Ther; 2017 Jun; 45(12):1542-1550. PubMed ID: 28449186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prescribing proton pump inhibitors for initial treatment of acid-related gastrointestinal diseases in a managed care population.
    Chan J; Hui RL; Szpakowski JL
    Am J Manag Care; 2004 Jul; 10(7 Pt 1):433-41. PubMed ID: 15298365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
    Richter JE; Campbell DR; Kahrilas PJ; Huang B; Fludas C
    Arch Intern Med; 2000 Jun; 160(12):1803-9. PubMed ID: 10871974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Nationwide Population-Based Cohort Study of Dementia Risk Among Acid Suppressant Users.
    Hwang IC; Chang J; Park SM
    Am J Geriatr Psychiatry; 2018 Nov; 26(11):1175-1183. PubMed ID: 30072307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.